pharmaceutical-investing FDA Approves SEYSARA (Sarecycline) for the Treatment of Moderate to Severe Acne
pharmaceutical-investing Antares Receives FDA Approval of Xyosted (Testosterone Enanthate) Injection for Testosterone Replacement Therapy
FDA Approves Start of Innovative On-Ambulance Phase 2 Clinical Trial for Treatment of Acute Stroke by Diffusion Pharmaceuticals
pharmaceutical-investing Antares Pharma Announces FDA Approval of Generic EpiPen Utilizing VIBEX Auto Injector
pharmaceutical-investing EyeGate Announces FDA Approval of Two IDE Submissions for Ocular Bandage Gel
medical-device-investing Medtronic Receives FDA Approval for Less-Invasive Heart Pump Implant Procedure
